Old Web
English
Sign In
Acemap
>
authorDetail
>
Wanda Boyer
Wanda Boyer
University of California, San Francisco
Panobinostat
Induction chemotherapy
Cytarabine
Immunology
Hypomethylating agent
2
Papers
14
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Histone deacetylase inhibition with panobinostat combined with intensive induction chemotherapy in older patients with acute myeloid leukemia: Phase I study results
2019
Clinical Cancer Research
Matthew J. Wieduwilt
Nela Pawlowska
Scott Thomas
Rebecca L. Olin
Aaron C Logan
Lloyd E. Damon
Thomas F. J. Martin
McNancy Kang
Peter H. Sayre
Wanda Boyer
Karin M.L. Gaensler
Kirsten Anderson
Pamela N. Munster
Charalambos Andreadis
Show All
Source
Cite
Save
Citations (13)
Panobinostat-Augmented Cytarabine and Daunorubicin (7+3) Induction for Older Patients with AML or High-Risk MDS Is Well Tolerated and Results in Favorable Clinical Outcomes: The Panda Trial
2015
Blood
Matthew J. Wieduwilt
Scott Thomas
Rebecca L. Olin
Aaron C Logan
Lloyd E. Damon
Thomas G. Martin
McNancy Kang
Peter H. Sayre
Wanda Boyer
Karin Gaensler
Kirsten Anderson
Pamela N. Munster
Charalambos Andreadis
Show All
Source
Cite
Save
Citations (1)
1